Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight

Details for Australian Patent Application No. 2004246820 (hide)

International Classifications

Event Publications

5 January 2006 PCT application entered the National Phase

PCT publication WO2004/110437 Priority application(s): WO2004/110437

11 January 2007 Assignment before Grant

Organon Ireland Ltd. The application has been assigned to N.V. Organon

1 October 2009 Application Accepted

Published as AU-B-2004246820

28 January 2010 Standard Patent Sealed

22 December 2011 Alteration of Name

The name of the patentee has been altered to MSD Oss B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.